4//SEC Filing
Mason Michael 4
Accession 0001209191-22-048394
CIK 0001503802other
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 8:59 PM ET
Size
7.4 KB
Accession
0001209191-22-048394
Insider Transaction Report
Form 4
Mason Michael
SVP, CFO & Treasurer
Transactions
- Award
Stock Option (right to buy)
2022-08-31+45,000→ 45,000 totalExercise: $5.06Exp: 2032-08-30→ Common Stock (45,000 underlying) - Award
Common Stock
2022-08-31+30,000→ 168,509 total
Footnotes (2)
- [F1]Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan (the "Plan"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest as to 50% of the shares on August 31, 2023, with the remaining 50% vesting on August 31, 2024.
- [F2]This option was granted on August 31, 2022 pursuant to the Plan. The shares underlying this option vest as to 50% of the shares on August 31, 2023, with the remaining 50% vesting on August 31, 2024.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001514291
Filing Metadata
- Form type
- 4
- Filed
- Aug 31, 8:00 PM ET
- Accepted
- Sep 1, 8:59 PM ET
- Size
- 7.4 KB